IONTAS to generate antibodies with favourable, binding and expression properties using their Mammalian Display Antibody Discovery Platform   Cambridge, UK: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, announced today that it has signed an agreement with Sanofi to discover antibodies using IONTAS’ proprietary Mammalian Display Technology.   IONTAS’ […]

Collaboration promises better, more reproducible biomedical data BOSTON, Mass. — BioBright, a firm dedicated to creating the smart laboratory of the future, has announced a collaboration with the Wellcome Sanger Institute that could lead to the faster development of drugs for diseases of the immune system like rheumatoid arthritis. BioBright tools automate the data collection and analysis that currently […]

Two additional laboratories have now achieved certification to provide Oxford Nanopore sequencing as a service.  There are now service providers operating in Europe, the US, China and Australia. NextOmics (GrandOmics), China NextOmics, a GrandOmics company, has become the third laboratory to certify for service provision of nanopore sequencing. The companies are based in Wuhan and […]

regenHU and Wako Automation collaborate to promote 3D-bioprinting in drug-discovery in the USA regenHU appoints Wako Automation as their official systems integrator for the USA. Recent advances in 3D-Bioprinting provide a valuable tool in the fabrication of biomimetic tissue constructs which can be applied at various stages of drug discovery research and development. “The collaboration with regenHU […]

Arima-HiC services is selected by the prestigious G10K consortium to generate ‘near-gapless’ reference genome assemblies for all vertebrate order species (phase-1). In a second related story, Arima Genomics today launches an early access program for its rapid, robust and easy-to-use Arima-HiC kits to satisfy the high demand for Hi-C technology. San Diego, CA Arima Genomics, […]

Singapore – Vela Diagnostics signs a license agreement with the The University of California, San Francisco (UCSF) for two technologies, known as:  FLASH (Finding Low Abundance Sequences by Hybridization); and DASH (Depletion of Abundant Sequences of Hybridization) – innovative technologies for enriching rare sequences in nucleic acid libraries. This agreement provides the framework for Vela Diagnostics to use and practice the FLASH and DASH technologies […]

Phoenix will help to increase productivity, improve management workflows, and ensure high accuracy for pharmacokinetic/pharmacodynamic and toxicokinetic studies PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that the Brazilian National Health Surveillance Agency—ANVISA (Agência Nacional de Vigilância Sanitária)—is now also employing Certara’s Phoenix® WinNonlin® software for reviewing drug regulatory submissions. “Phoenix WinNonlin is […]

Coupling of technologies delivers advanced information with superior speed and resolution compared to traditional Gel Permeation Chromatography (GPC) MILFORD, Mass. — Waters Corporation (NYSE:WAT) announced that it entered into a co-marketing agreement with Malvern Panalytical to advance the analysis of polymers. By pairing the Waters®ACQUITY® Advanced Polymer Chromatography® (APC™) System with Malvern Panalytical’s OMNISEC® REVEAL, R&D scientists can access higher sensitivity, higher resolution […]

Collaboration to have disruptive impact on the world food supply Research Triangle Park, North Carolina, & Ness Ziona, Israel – Syngenta, a global leading agrochemical and seed company, and NRGene, the premier genomic big data company, have continued to advance their cooperation in breeding and trait discovery in key crops. Syngenta has licensed NRGene’s GenoMAGICTM, a cloud-based big data […]

Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that Novartis is implementing BLI’s Beacon platform to help accelerate their antibody discovery workflow. Novartis was an early adopter of the BLI technology and the results from this early work has culminated in the […]